These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 7705213)
41. Pilocarpine and carbacholine in treatment of radiation-induced xerostomia. Joensuu H; Boström P; Makkonen T Radiother Oncol; 1993 Jan; 26(1):33-7. PubMed ID: 8438084 [TBL] [Abstract][Full Text] [Related]
42. Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease: a sialometrical study. Nagler RM; Nagler A Bone Marrow Transplant; 1999 May; 23(10):1007-11. PubMed ID: 10373066 [TBL] [Abstract][Full Text] [Related]
43. Radiation-induced hyposalivation and its treatment with oral pilocarpine. Niedermeier W; Matthaeus C; Meyer C; Staar S; Müller RP; Schulze HJ Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Nov; 86(5):541-9. PubMed ID: 9830645 [TBL] [Abstract][Full Text] [Related]
44. Manifestations and treatment of xerostomia and associated oral effects secondary to head and neck radiation therapy. Garg AK; Malo M J Am Dent Assoc; 1997 Aug; 128(8):1128-33. PubMed ID: 9260423 [TBL] [Abstract][Full Text] [Related]
45. Determination of the efficacy of topical oral pilocarpine for postirradiation xerostomia in patients with head and neck carcinoma. Hamlar DD; Schuller DE; Gahbauer RA; Buerki RA; Staubus AE; Hall J; Altman JS; Elzinga DJ; Martin MR Laryngoscope; 1996 Aug; 106(8):972-6. PubMed ID: 8699911 [TBL] [Abstract][Full Text] [Related]
46. Pilocarpine for radiation-induced xerostomia in head and neck cancer. Hawthorne M; Sullivan K Int J Palliat Nurs; 2000 May; 6(5):228-32. PubMed ID: 12419994 [TBL] [Abstract][Full Text] [Related]
47. Salivary hypofunction and xerostomia: diagnosis and treatment. Atkinson JC; Grisius M; Massey W Dent Clin North Am; 2005 Apr; 49(2):309-26. PubMed ID: 15755407 [TBL] [Abstract][Full Text] [Related]
48. A multicenter maintenance study of oral pilocarpine tablets for radiation-induced xerostomia. Jacobs CD; van der Pas M Oncology (Williston Park); 1996 Mar; 10(3 Suppl):16-20. PubMed ID: 8723429 [TBL] [Abstract][Full Text] [Related]
49. Benefits of long-term pilocarpine due to increased muscarinic acetylcholine receptor 3 in salivary glands. Minagi HO; Ikai K; Araie T; Sakai M; Sakai T Biochem Biophys Res Commun; 2018 Sep; 503(2):1098-1102. PubMed ID: 29953856 [TBL] [Abstract][Full Text] [Related]
50. Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer. Gornitsky M; Shenouda G; Sultanem K; Katz H; Hier M; Black M; Velly AM Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Jul; 98(1):45-52. PubMed ID: 15243470 [TBL] [Abstract][Full Text] [Related]
51. Functional outcomes related to the prevention of radiation-induced xerostomia: oral pilocarpine versus submandibular salivary gland transfer. Rieger JM; Jha N; Lam Tang JA; Harris J; Seikaly H Head Neck; 2012 Feb; 34(2):168-74. PubMed ID: 21416547 [TBL] [Abstract][Full Text] [Related]
52. Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients. de Castro G; Federico MH Curr Opin Oncol; 2006 May; 18(3):266-70. PubMed ID: 16552239 [TBL] [Abstract][Full Text] [Related]
53. Salivary gland dysfunction: a review of systemic therapies. Grisius MM Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):156-62. PubMed ID: 11505261 [TBL] [Abstract][Full Text] [Related]
54. Effects of pilocarpine hydrochloride and cevimeline on submandibular/sublingual salivation in rat xerostomia model produced by X-ray irradiation. Omori Y; Asari T; Maruyama K; Kusama H; Kojima M; Shibata N Arzneimittelforschung; 2003; 53(5):342-50. PubMed ID: 12854361 [TBL] [Abstract][Full Text] [Related]
55. Effect of pilocarpine mouthwash on salivary flow. Bernardi R; Perin C; Becker FL; Ramos GZ; Gheno GZ; Lopes LR; Pires M; Barros HM Braz J Med Biol Res; 2002 Jan; 35(1):105-10. PubMed ID: 11743622 [TBL] [Abstract][Full Text] [Related]
56. Efficacy and safety of pilocarpine for radiation-induced xerostomia in patients with head and neck cancer: A systematic review and meta-analysis. Cheng CQ; Xu H; Liu L; Wang RN; Liu YT; Li J; Zhou XK J Am Dent Assoc; 2016 Apr; 147(4):236-43. PubMed ID: 26563850 [TBL] [Abstract][Full Text] [Related]
57. A new medication for treatment of dry mouth in Sjögren's syndrome. al-Hashimi I; Taylor SE Tex Dent J; 2001 Apr; 118(3):262-6. PubMed ID: 11404944 [TBL] [Abstract][Full Text] [Related]
58. Decreased salivary flow rate as a dipsogenic factor in hemodialysis patients: evidence from an observational study and a pilocarpine clinical trial. Sung JM; Kuo SC; Guo HR; Chuang SF; Lee SY; Huang JJ J Am Soc Nephrol; 2005 Nov; 16(11):3418-29. PubMed ID: 16177001 [TBL] [Abstract][Full Text] [Related]
59. A randomized, double-blind, placebo-controlled trial of concomitant pilocarpine with head and neck irradiation for prevention of radiation-induced xerostomia. Haddad P; Karimi M Radiother Oncol; 2002 Jul; 64(1):29-32. PubMed ID: 12208571 [TBL] [Abstract][Full Text] [Related]
60. Tramadol-induced oral dryness and pilocarpine treatment: effects on total protein and IgA. Looström H; Akerman S; Ericson D; Tobin G; Götrick B Arch Oral Biol; 2011 Apr; 56(4):395-400. PubMed ID: 21112044 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]